Travere Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Travere Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 31% to $145,238,000. The net income raised on -$111,399,000 and profit margin reached -77%. Total operating expenses were $521,926,000.
Profit Margin
| 2014 | 28.20M | -110.93M | -393.35% |
|---|---|---|---|
| 2015 | 99.89M | 117.23M | 117.36% |
| 2016 | 133.59M | -47.90M | -35.86% |
| 2017 | 154.93M | -59.73M | -38.55% |
| 2018 | 164.24M | -102.67M | -62.51% |
| 2019 | 175.33M | -146.42M | -83.51% |
| 2020 | 198.32M | -169.43M | -85.43% |
| 2021 | 227.49M | -180.09M | -79.16% |
| 2022 | 212.01M | -278.48M | -131.35% |
| 2023 | 145.23M | -111.39M | -76.7% |
TVTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 145.23M | 212.01M | 227.49M | 198.32M | 175.33M | 164.24M | 154.93M | 133.59M | 99.89M | 28.20M |
Cost of revenue | 11.45M | 7.59M | 6.78M | 6.12M | 5.23M | 5.52M | 3.60M | 4.55M | 2.18M | 570.97K |
Gross profit | 133.78M | 204.42M | 220.70M | 192.19M | 170.10M | 158.71M | 151.33M | 129.03M | 97.70M | 27.63M |
Operating exp. | ||||||||||
Research and development | 244.99M | 235.78M | 210.32M | 131.77M | 140.96M | 123.75M | 78.16M | 70.85M | 50.42M | 47.79M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 521.92M | 455.98M | 360.21M | 267.57M | 269.91M | 227.41M | 182.12M | 168.86M | 129.96M | 107.43M |
Operating income | -376.74M | -251.56M | -139.50M | -75.37M | -99.81M | -80.04M | -53.79M | -58.21M | -50.74M | -79.80M |
Other income (expenses), net | 634K | -26.60M | -40.17M | -113.41M | -46.63M | -28.86M | -30.19M | -16.99M | 156.21M | -33.88M |
Income before tax | -376.11M | -278.16M | -179.68M | -188.79M | -146.44M | -101.86M | -58.36M | -57.58M | 105.46M | -113.39M |
Income tax expense | 223K | 313K | 409K | -19.35M | -21K | 811K | 1.36M | -9.67M | -11.77M | -2.45M |
Net income | -111.39M | -278.48M | -180.09M | -169.43M | -146.42M | -102.67M | -59.73M | -47.90M | 117.23M | -110.93M |
Earnings per share | ||||||||||
Basic EPS | -1.5 | -4.37 | -3.01 | -3.56 | -3.46 | -2.54 | -1.54 | -1.29 | 3.49 | -4.43 |
Diluted EPS | -1.5 | -4.37 | -3.01 | -3.56 | -3.46 | -2.54 | -1.54 | -1.25 | 3.17 | -4.43 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |